New hope for frail blood cancer patients: testing a Triple-Threat drug combo

NCT ID NCT04266795

Summary

This study tested whether adding a new drug called pevonedistat to a standard two-drug combination works better for adults newly diagnosed with acute myeloid leukemia (AML) who are too frail for intensive chemotherapy. About 164 participants worldwide were randomly assigned to receive either the three-drug combination or the standard two-drug combination in 28-day treatment cycles. The main goal was to see which group had longer event-free survival, meaning more time without the cancer getting worse or causing death.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • ASST di Monza - Azienda Ospedaliera San Gerardo

    Monza, Lombardy, 20900, Italy

  • AdventHealth (Florida Hospital) - Transplant Institute

    Orlando, Florida, 32804, United States

  • Avera Cancer Institute

    Sioux Falls, South Dakota, 57105, United States

  • Azienda Ospedaliera Citta della Salute e della Scienza di Torino

    Turin, Piedmont, 10126, Italy

  • Azienda Ospedaliera Universitaria Careggi

    Florence, 50134, Italy

  • Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi

    Bologna, 40138, Italy

  • Azienda Sanitaria Ospedaliera S Luigi Gonzaga

    Orbassano, Piedmont, 10043, Italy

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona, 85234, United States

  • CHRU Lille

    Lille, 59037, France

  • CHRU Nantes

    Nantes, 44093, France

  • CHRU de Poitiers La Miletrie

    Poitiers, 86021, France

  • CHU de Grenoble

    Grenoble, 38043, France

  • CHU de Nice

    Nice, 06202, France

  • Centre Hospitalier Le Mans

    Le Mans, Sarthe, 72000, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495, France

  • EDOG - Institut Claudius Regaud - PPDS

    Toulouse, 31059, France

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    Pavia, 27100, Italy

  • Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli

    Reggio Calabria, Calabria, 89133, Italy

  • HCA Midwest Health - SCRI - PPDS

    Kansas City, Missouri, 64132, United States

  • Hopital Avicenne

    Bobigny, 93009, France

  • Hopital Saint Antoine

    Paris, 75012, France

  • Hopital Saint Louis

    Paris, 75475, France

  • Hopital de L'enfant Jesus

    Québec, Quebec, G1J 1Z4, Canada

  • Houston Methodist Cancer Center

    Houston, Texas, 77030, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029-6574, United States

  • Institut dHematologie de Basse Normandie

    Caen, 14033, France

  • Instytut Hematologii i Transfuzjologii

    Warsaw, Masovian Voivodeship, 02-776, Poland

  • Intermountain LDS Hospital

    Salt Lake City, Utah, 84143, United States

  • Istituto Clinico Humanitas

    Rozzano, Milano, 20089, Italy

  • Joe Arrington Cancer Research and Treatment Center

    Lubbock, Texas, 79410, United States

  • London Health Sciences Centre

    London, Ontario, N6A 5W9, Canada

  • MTZ Clinical Research Sp z o o

    Warsaw, Masovian Voivodeship, 02-106, Poland

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Northwell Health Cancer Institute

    Lake Success, New York, 11042, United States

  • Norton Cancer Institute - Suburban

    Louisville, Kentucky, 40207, United States

  • Ospedale Santa Maria Della Misericordia Di Perugia

    Perugia, Umbria, 06156, Italy

  • Ottawa Hospital

    Ottawa, Ontario, K1H 8L6, Canada

  • Rhode Island Hospital

    Providence, Rhode Island, 02903, United States

  • Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie

    Lublin, 20-081, Poland

  • Stony Brook Medicine

    Stony Brook, New York, 11794, United States

  • Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy

    Bydgoszcz, 85-168, Poland

  • Szpital Uniwersytecki w Krakowie

    Krakow, Lesser Poland Voivodeship, 31-501, Poland

  • The University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73104, United States

  • Tom Baker Cancer Centre

    Tom Baker Cancer Centre, Alberta, T2N 4N2, Canada

  • Tulane Medical Center

    New Orleans, Louisiana, 70112, United States

  • UC Irvine Medical Center

    Orange, California, 92868, United States

  • UC San Diego Moores Cancer Center

    La Jolla, California, 92093, United States

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106, United States

  • University of Alberta

    Edmonton, Alberta, T6G 2G3, Canada

  • University of Miami Miller School of Medicine

    Miami, Florida, 33136, United States

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27514-4221, United States

  • University of Virginia Health System

    Charlottesville, Virginia, 22908, United States

  • Uniwersytecki Szpital Kliniczny w Bialymstoku

    Bialystok, Podlaskie Voivodeship, 15-276, Poland

  • Uniwersyteckie Centrum Kliniczne

    Gdansk, 80-952, Poland

  • West Virginia University Hospital

    Morgantown, West Virginia, 26506, United States

  • Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi

    Lodz, Łódź Voivodeship, 93-513, Poland

Conditions

Explore the condition pages connected to this study.